Health
FDA Requires New Eye-Risk Warnings on GLP-1 Drugs
The FDA found very few probable cases, but is requiring labels to flag a rare condition that can cause sudden, painless vision loss.
shahzad · · 7 min read
3 results for "clinical trial"
The FDA found very few probable cases, but is requiring labels to flag a rare condition that can cause sudden, painless vision loss.
shahzad · · 7 min read
A trial in adults 70+ met its two-year noninferiority threshold, but the group that stopped statins had more cardiovascular events.
shahzad · · 8 min read
A new FDA-approved stroke-prevention pill cut ischemic stroke risk by 26% in a 12,327-person trial, but its use is limited to specific patients.
shahzad · · 7 min read